Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Assets Average (2024 - 2025)

Historic Assets Average for Contineum Therapeutics (CTNM) over the last 2 years, with Q3 2025 value amounting to $186.9 million.

  • Contineum Therapeutics' Assets Average fell 1455.32% to $186.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.9 million, marking a year-over-year decrease of 1455.32%. This contributed to the annual value of $171.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Assets Average of $186.9 million as of Q3 2025, which was down 1455.32% from $190.6 million recorded in Q2 2025.
  • Contineum Therapeutics' Assets Average's 5-year high stood at $218.7 million during Q3 2024, with a 5-year trough of $127.0 million in Q1 2024.